Landscapes / Companies
Antengene Biologics Limited not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 4 in all
Trials
4 active
6 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 30 Sep 2027Phase 1/2 trial completes | |||
| Next date | 30 Sep 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced/Metastatic Solid Tumors, Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Dec 2028Phase 1 trial completes | |||
| Next date | 1 Dec 2028 · Phase 1 trial completes | ||||
| Also tested for | Systemic Lupus Erythematosus, Systemic Sclerosis (SSc) and 2 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021